The World Health Organisation has validated Guyana’s elimination of mother-to-child transmission of HIV and syphilis as public health problems, covering 2022 to 2025, officials announced on 19 November 2026.
The decision follows years of screening, treatment and surveillance work, according to INews Guyana. It does not mean either infection has been eradicated. Guyana must maintain its services and submit to another WHO review in 2030, covering performance from 2026 through 2029.
What WHO validation means for Guyana
WHO Director-General Dr Tedros Adhanom Ghebreyesus informed Health Minister Dr Frank Anthony of the decision in a letter dated 16 November 2026. The WHO Global Validation Advisory Committee had assessed Guyana’s submission on 5 November.
“Guyana has been validated as having achieved the elimination of mother-to-child transmission (EMTCT) of HIV and syphilis for the period 2022-2025. I congratulate Guyana on this landmark achievement,” Dr Tedros wrote.
Validation confirms that transmission has fallen to internationally accepted elimination levels as a public health problem. HIV and syphilis can still pass from a pregnant woman to her child, making continued antenatal screening, prompt treatment and reliable monitoring essential.
Without timely care, these infections can cause lifelong illness, stillbirth and neonatal death. The Health Ministry said Guyana’s programme expanded screening and treatment while improving laboratories, disease surveillance and maternal and child health services.
How international reviewers assessed the programme
The Pan American Health Organisation coordinated a detailed assessment before WHO issued its decision. A virtual review ran from 1 to 5 June 2026, followed by an in-country mission from 7 to 13 June.
Dr Jodie Dionne led the regional validation team, which examined national programmes, health services, laboratory systems, epidemiological data and community engagement. Its remit also included human rights and gender considerations, an indication that elimination depends on access and patient treatment as well as laboratory results.
The team comprised Dr Shabbir Argaw, María Belén, Arlene Darmaine, Diane Weeks, Veronica Cenac and Patrick Lalor. Sandra Jones and Dr Leandro Sereno Soares of PAHO provided support.
After an initial briefing with Anthony on 8 June, the reviewers presented their technical findings to Guyana’s National Validation Team on 12 June. WHO’s global committee then completed the process in November.
Public spending must keep producing evidence
The government credited sustained investment under President Dr Mohamed Irfaan Ali, including spending on hospitals, primary care, diagnostic equipment and health workforce development. Anthony described the validation as evidence that those investments were protecting lives.
“This is more than an international certificate. It represents lives protected, infections prevented, and children given a healthier start in life,” Anthony said.
“I want to recognise the doctors, nurses, midwives, laboratory professionals, public health officers and community health workers whose dedication has made this possible,” he added, while thanking PAHO, WHO and development partners.
The policy lesson is narrower than a general case for higher spending. Screening, treatment, laboratories and surveillance are specific services with measurable outcomes. Their value should be judged by those outcomes, not by the size of budget lines or the number of buildings opened.
For taxpayers, transparent reporting is the next safeguard. Regular publication of screening coverage, treatment results and surveillance data would allow citizens to see whether the standards recognised by WHO are being maintained across Guyana.
Regional progress and Guyana’s next targets
Guyana joins a small group of countries in Latin America and the Caribbean with this recognition. UNAIDS records that Cuba became the first country certified by WHO and PAHO for dual elimination in 2015.
Elsewhere in the region, Tringlobe Media News reported that Barbados had reached an HIV milestone, while Trinidad and Tobago was working towards certification. The results point to a wider Caribbean effort built around antenatal care and disease monitoring.
Guyana’s validation also contributes to PAHO’s Disease Elimination Initiative, which aims to eliminate more than 30 communicable diseases and related conditions as public health problems by 2030.
The government’s next objective is triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B. Dr Tedros said WHO would continue technical cooperation with Guyana towards that goal.
Anthony said the immediate responsibility was to preserve the present gains. “No child in Guyana should suffer from an infection that modern medicine can prevent,” he said.
Guyana HIV and syphilis elimination: FAQ
Has Guyana eradicated HIV and syphilis?
No. WHO validation covers elimination of mother-to-child transmission as a public health problem during 2022 to 2025. Both infections remain, so prevention, testing and treatment must continue.
When will Guyana face another WHO review?
WHO will review Guyana again in 2030. That assessment will examine programme performance during 2026 to 2029, giving health authorities a clear period over which to demonstrate consistent results.
What is Guyana’s next elimination goal?
Guyana is working towards triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B. WHO has pledged continued technical cooperation, while the Health Ministry plans to maintain screening, treatment and surveillance.
